MAY 24, 2019 2:36 PM PDT

New Therapeutic Target for Depression

WRITTEN BY: Nouran Amin

In a study published in the Journal of Psychopharmacology, a new drug target for the treatment of depression has been identified by researchers at the Department of Human Physiology of the UMA Faculty of Medicine.

The study stemmed from the research group, “Neurochemistry of the Transmission in the Central Nervous System”, co-directed by Professor Zaida Díaz-Cabiale, where they identified ‘GAL (1-15)’--part of the neuropeptide molecule called Galanin.

Galanin is central to the common symptom of depression—anhedonia, the loss of pleasure in daily activities.

“We have verified through different experiments how animals modify their response to high-reinforcement appetitive stimuli, such as saccharine or sexual attraction, after the administration of the Galanin fragment”, explains researcher Carmelo Millón, one of the authors of this study. “The understanding of these mechanisms opens the way for endless therapeutic strategies, hence its importance.”

Researchers from Karolinska Institute in Sweden also collaborated on the study and examined the molecular interactions of brain reinforcement system. They observed that the brains' ability to support positive behavior was inhibited by the Galanin fragment which reaffirmed the initial findings.

Most therapeutics for depression are SSRIs (selective serotonin reuptake inhibitors)—such drugs can take up to two weeks to start showing signs of treatment with a further 30 percent of patients who receive the medication are resistant to the treatment.

Learn more about the future of depression treatments:

Source: Drug Target Review

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 02, 2019
Drug Discovery & Development
DEC 02, 2019
New Ultrasound Treatment for Parkinson's Tremors
A non-invasive ultrasound procedure may provide lasting relief from tremors in people with Parkinson’s disease (PD) and essential tremor (ET), accord...
DEC 09, 2019
Drug Discovery & Development
DEC 09, 2019
Could the diabetic drug 'metformin' extend a healthy lifespan?
The most commonly prescribed diabetic medication for the Type 2 condition is ‘Metformin’—a drug with a mysterious mechanism of action but...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
JAN 03, 2020
Drug Discovery & Development
JAN 03, 2020
Researchers Grow Psilocybin from E. Coli Bacteria
Previously considered to be narcotic, and under tight regulation as an illicit drug for decades, research from recent years on the possible medicinal prope...
JAN 09, 2020
Drug Discovery & Development
JAN 09, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
Loading Comments...